International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.14

Issue per Year : 12

Volume Published : 8

Issue Published : 88

Article Submitted : 8806

Article Published : 4513

Total Authors : 11718

Total Reviewer : 551

Total Countries : 87

Indexing Partner


This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: Precision Medicines and Its Targeted activity in Multiple types of Breast Cancer
Authors Name: Ms. Pooja S Murkute , Mr. Aditya A More , Mr. Nakul P Kathar , Dr. Gajanan.S. Sanap , Mr. Rahul R Pawar
Download E-Certificate: Download
Author Reg. ID:
Published Paper Id: IJRTI2202009
Published In: Volume 7 Issue 2, February-2022
Abstract: Precision medicine is a medicine advance to the genotypic and phenotypic feature of an individual. It has host of destination including gene and their transcript protein and metabolite. Precision medicine and targeted therapies have long record in treatment of breast cancer. Breast cancer is the most common cancer among women is a highly complex, heterogeneous and multifactorial disease. It is cancer that start in breast when cells begin to grow out of control. Breast cancer have demonstrated prediction and support advantage thanks to the discovery of targeted therapies the advent of these new approaches marked the rise of precision medicine, which lead to improve the diagnosis, prediction and treatment of cancer. This article describes the important of precision medicine and targeted therapies in breast cancer
Keywords: Breast Cancer, Precision Medicine, Triple-Negative Breast Cancer, BRC A1, BRC A2, HER2 targeted medicine, Pertuzumab, Trastuzumab-DM1, Neratinib, Trastuzumab
Cite Article: "Precision Medicines and Its Targeted activity in Multiple types of Breast Cancer", International Journal of Science & Engineering Development Research (www.ijrti.org), ISSN:2455-2631, Vol.7, Issue 2, page no.57 - 66, February-2022, Available :http://www.ijrti.org/papers/IJRTI2202009.pdf
Downloads: 000202614
ISSN: 2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID: IJRTI2202009
Registration ID:181703
Published In: Volume 7 Issue 2, February-2022
DOI (Digital Object Identifier):
Page No: 57 - 66
Country: AURANGABAD, Maharashtra, India
Research Area: Pharmacy
Publisher : IJ Publication
Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2202009
Published Paper PDF: https://www.ijrti.org/papers/IJRTI2202009
Share Article:

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijrti.org
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX DOAJ : Directory of Open Access Journals
DRJI Index Copernicus International Scribd DocStoc

ISSN Details

ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)

Providing A digital object identifier by DOI.ONE
How to Get DOI?


Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Social Media

Join RMS/Earn 300


Indexing Partner